Friess Associates LLC Aspira Women'S Health Inc. Transaction History

Friess Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.63 - $3.43 $2.25 Million - $4.74 Million	-1,382,045 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.19 - $5.48 $193,945 - $333,173	-60,798 Reduced 4.21%	1,382,045 $4.49 Million
Q2 2021 Aug 11, 2021	BUY	$4.78 - $6.84 $320,828 - $459,093	67,119 Added 4.88%	1,442,843 $8.11 Million
Q1 2021 May 14, 2021	BUY	$5.9 - $9.13 $1.62 Million - $2.51 Million	275,080 Added 24.99%	1,375,724 $9.29 Million
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.71 $817,932 - $1.83 Million	272,644 Added 32.93%	1,100,644 $7.39 Million
Q3 2020 Nov 13, 2020	BUY	$2.54 - $4.56 $2.1 Million - $3.78 Million	828,000 New	828,000 $2.55 Million

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.